Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Davidson, M H
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. [electronic resource] - JAMA Jan 1999 - 235-42 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0098-7484
10.1001/jama.281.3.235 doi
Adult
Analysis of Variance
Blood Glucose
Blood Pressure
Cardiovascular Diseases--etiology
Double-Blind Method
Energy Intake
Enzyme Inhibitors--therapeutic use
Female
Follow-Up Studies
Humans
Insulin--blood
Lactones--therapeutic use
Lipase--antagonists & inhibitors
Lipids--blood
Male
Obesity--complications
Orlistat
Risk Factors
Weight Loss
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. [electronic resource] - JAMA Jan 1999 - 235-42 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0098-7484
10.1001/jama.281.3.235 doi
Adult
Analysis of Variance
Blood Glucose
Blood Pressure
Cardiovascular Diseases--etiology
Double-Blind Method
Energy Intake
Enzyme Inhibitors--therapeutic use
Female
Follow-Up Studies
Humans
Insulin--blood
Lactones--therapeutic use
Lipase--antagonists & inhibitors
Lipids--blood
Male
Obesity--complications
Orlistat
Risk Factors
Weight Loss